Ibrance (palbociclib)

**Product type:** Human Prescription Drug

**Active ingredient:** PALBOCICLIB

**Strength:** 75 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** U.S. Pharmaceuticals

**Marketing category:** NDA (NDA207103)

**Pharmacologic class:** Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]